Table 4 Morbidity and mortality following total pelvic exenteration for colorectal and non-colorectal tumors
From: Retrospective review of pelvic malignancies undergoing total pelvic exenteration
Complications (percent) | Colorectaln = 36 | Non-colorectaln = 17 | P value |
|---|---|---|---|
Overall | 31 (86%) | 13 (76%) | 0.44 |
Wound infection | 18 (50%) | 6 (35%) | 0.38 |
Wound dehiscence | 8 (22%) | 3 (18%) | 1.00 |
Pelvic abscess | 20 (56%) | 5 (29%) | 0.09 |
Perineal abscess | 10 (28%) | 0 (0%) | 0.02 |
Enteric fistula | 11 (31%) | 3 (18%) | 0.51 |
Sepsis | 16 (44%) | 5 (29%) | 0.37 |
Bleeding | 7 (19%) | 1 (6%) | 0.41 |
Respiratory failure | 10 (28%) | 2 (12%) | 0.30 |
Deep venous thrombosis | 7 (19%) | 1 (6%) | 0.41 |
30-day morbidity | 29 (81%) | 11 (65%) | 0.31 |
30-day mortality | 0 (0%) | 0 (0%) | 1.00 |